Hainsworth, John D.
Murphy, Patrick B.
Alemar, Jose R.
Daniel, Brooke R.
Young, Robyn R.
Yardley, Denise A.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy
https://doi.org/10.1007/s10549-016-3969-7
Funding for this research was provided by:
Genentech
Prometheus
Article History
Received: 15 June 2016
Accepted: 29 August 2016
First Online: 8 September 2016
Compliance with ethical standards
:
: JDH received funding to his institution for the study from Genentech and Prometheus. All the other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.